References

A population-based study of the three major variants of papillary thyroid carcinoma

10.1177/0300060520984618 · 2021 · External reference

Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study

10.1002/cncr.21653 · 2006 · External reference

Skip metastasis in papillary thyroid carcinoma is difficult to predict in clinical practice

10.1186/s12885-017-3698-2 · 2017 · External reference

Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer

10.1016/s0039-6060(03)00424-0 · 2003 · External reference

2024 international expert consensus on US-guided thermal ablation for T1N0M0 papillary thyroid cancer

10.1148/radiol.240347 · 2025 · External reference

A clinical study of microwave ablation for cervical lymph node metastasis from papillary thyroid cancer

10.3389/fendo.2025.1580765 · 2025 · External reference

Ablation techniques in non-small cell lung cancer patients: experience of a single center

2022 · External reference

Thermal ablation in non-small cell lung cancer: a review of treatment modalities and the evidence for combination with immune checkpoint inhibitors

10.21037/tlcr-20-1075 · 2021 · External reference

A preliminary comparative study of microwave ablation for cervical lymph node metastases originating from papillary thyroid carcinoma vs. non-papillary thyroid carcinoma

10.1080/02656736.2025.2553205 · 2025 · External reference

The value of Ki-67 labeling index in central lymph node metastasis and survival of papillary thyroid carcinoma: evidence from the clinical and molecular analyses

10.1177/10732748231155701 · 2023 · External reference

Kank1 and Ki67 expression are associated with poor prognosis in human pulmonary adenocarcinoma

2020 · External reference

Tumor cell proliferation (Ki-67) expression and its prognostic significance in histological subtypes of lung adenocarcinoma

10.1016/j.lungcan.2021.02.009 · 2021 · External reference

Comparison of proliferating cell nuclear antigen, thyroid transcription factor-1, Ki-67, p63, p53 and high-molecular weight cytokeratin expressions in papillary thyroid carcinoma, follicular carcinoma, and follicular adenoma

10.1016/j.anndiagpath.2010.11.005 · 2011 · External reference

Anaplastic transformation of papillary thyroid carcinoma in recurrent disease in regional lymph nodes: a histologic and immunohistochemical study

10.1002/(sici)1096-9098(199901)70:1<45::aid-jso8>3.0.co;2-b · 1999 · External reference

Utility of BRAF protein overexpression in predicting the metastasis potential of papillary thyroid carcinoma

10.3892/ol.2010.219 · 2011 · External reference

Clinical significance of p53 protein expression in papillary thyroid carcinoma

10.1007/s00268-008-9756-9 · 2008 · External reference

Prognostic impact of TP53 mutations in metastatic nonsquamous non-small-cell lung cancer

10.1016/j.cllc.2023.12.004 · 2024 · External reference

TP53 mutation is associated with a poor clinical outcome for non-small cell lung cancer: evidence from a meta-analysis

10.3892/mco.2016.1057 · 2016 · External reference

MMP-9-1562 C/T single nucleotide polymorphism associates with increased MMP-9 level and activity during papillary thyroid carcinoma progression

10.1016/j.pathol.2018.10.008 · 2019 · External reference

Inhibition of metalloproteinases-2, -9, and -14 suppresses papillary thyroid carcinoma cell migration and invasion

10.3390/ijms26167956 · 2025 · External reference

Correlation between matrix metalloproteinase-9 and vascular endothelial growth factor expression in lung adenocarcinoma

10.4238/2015.december.29.44 · 2015 · External reference